Cigna Group (CI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 25B 50B 75B Q3 '21: 44.3B Q4 '21: 45.7B Q1 '22: 44B Q2 '22: 45.5B Q3 '22: 45.3B Q4 '22: 45.8B Q1 '23: 46.5B Q2 '23: 48.6B Q3 '23: 49B Q4 '23: 51.1B Q1 '24: 57.3B Q2 '24: 60.5B Q3 '24: 63.7B Q4 '24: 65.6B Q1 '25: 65.5B Q2 '25: 67.2B Q3 '25: 69.7B Q4 '25: 72.5B Q1 '26: 68.5B Q2 '26: 71.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 1B 2B 3B Q3 '21: 2.3B Q4 '21: 1.5B Q1 '22: 2.2B Q2 '22: 2.4B Q3 '22: 2.1B Q4 '22: 1.7B Q1 '23: 2B Q2 '23: 2.2B Q3 '23: 2.2B Q4 '23: 2.1B Q1 '24: 2.3B Q2 '24: 2.4B Q3 '24: 2.6B Q4 '24: 2.2B Q1 '25: 2B Q2 '25: 2.3B Q3 '25: 2.6B Q4 '25: 2.3B Q1 '26: 2.4B Q2 '26: 2.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-1B 0 1B 2B 3B Q3 '21: 1.6B Q4 '21: 1.1B Q1 '22: 1.2B Q2 '22: 1.6B Q3 '22: 2.8B Q4 '22: 1.2B Q1 '23: 1.3B Q2 '23: 1.5B Q3 '23: 1.4B Q4 '23: 1.1B Q1 '24: -212M Q2 '24: 1.6B Q3 '24: 825M Q4 '24: 1.5B Q1 '25: 1.3B Q2 '25: 1.5B Q3 '25: 2B Q4 '25: 1.3B Q1 '26: 1.7B Q2 '26: 1.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 20B 40B 60B Q3 '21: 30.1B Q4 '21: 31.2B Q1 '22: 29.8B Q2 '22: 31.1B Q3 '22: 31.8B Q4 '22: 32.1B Q1 '23: 31.5B Q2 '23: 33.4B Q3 '23: 33.6B Q4 '23: 35.3B Q1 '24: 41.4B Q2 '24: 44.5B Q3 '24: 47.6B Q4 '24: 49B Q1 '25: 48.4B Q2 '25: 53.3B Q3 '25: 55.5B Q4 '25: 57.8B Q1 '26: 54.1B Q2 '26: 56.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-2.5B 0 2.5B 5B 7.5B Q3 '21: 2.1B Q4 '21: 4.3B Q1 '22: 2B Q2 '22: 1.2B Q3 '22: 3.3B Q4 '22: 2.1B Q1 '23: 5B Q2 '23: 2.5B Q3 '23: 2.8B Q4 '23: 1.5B Q1 '24: 4.8B Q2 '24: 265M Q3 '24: 46M Q4 '24: 5.2B Q1 '25: 1.9B Q2 '25: -1.9B Q3 '25: 3.4B Q4 '25: 6.1B Q1 '26: 1.1B Q2 '26: -421M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-1.5B 0 1.5B 3B 4.5B Q1 '18: 1.9B Q2 '18: 878M Q3 '18: 498M Q4 '18: -56M Q1 '19: 3B Q2 '19: 736M Q3 '19: 2.2B Q4 '19: 2.5B Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 374.6M Q2 '20: 370.7M Q3 '20: 367.2M Q1 '21: 352M Q2 '21: 344.9M Q3 '21: 337.6M Q1 '22: 321.3M Q2 '22: 318.3M Q3 '22: 307.5M Q1 '23: 299M Q2 '23: 296.9M Q3 '23: 297.1M Q1 '24: 286.5M Q2 '24: 284.1M Q3 '24: 281.4M Q1 '25: 273M Q2 '25: 268.2M Q3 '25: 267.5M Q1 '26: 264M Q2 '26: 264M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 9.00 18.00 27.00 Q3 '21: 23.65 Q4 '21: 15.78 Q1 '22: 16.21 Q2 '22: 16.85 Q3 '22: 21.02 Q4 '22: 21.54 Q1 '23: 22.05 Q2 '23: 22.08 Q3 '23: 17.85 Q4 '23: 17.40 Q1 '24: 12.19 Q2 '24: 12.72 Q3 '24: 10.61 Q4 '24: 12.18 Q1 '25: 18.00 Q2 '25: 18.26 Q3 '25: 22.61 Q4 '25: 22.20 Q1 '26: 23.61 Q2 '26: 24.19 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.